Skip to content

Meet Revel

Revel

Revel's story

HRT Access Fund recipient

Revel (they/them) is non-binary/gender-fluid and has experienced healthcare discrimination as a neurodivergent person of color. They have struggled with psychological and financial barriers to care. When insured, the gels they needed weren’t covered and out of financial reach. Now that they are unemployed, it is even more of a challenge. Revel has said that receiving HRT would help them connect to their body and healing.

Revel's timeline

  • Award Granted

    December 31, 2020

    Revel was awarded a grant toward HRT/GaHT!
  • HRT Onboarding Date

    January 3, 2021

    Revel was seen by their HRT/GaHT provider.

Grant details

$1,700 towards gender-affirming care.





About Estrogen+

On average, it costs $1,700+/year for Revel's care.

What is it?

Estrogen+ refers to the gender-affirming hormone replacement therapy (HRT) methods that some trans women, trans femme, and non-binary people take that result in physical changes which align with their gender identity. Every person's preferences and personal healthcare needs vary, so this can include oral medications, injections, and transdermal patches.

How accessible is it for trans folks to receive this care?

For trans folks who live in states most impacted by anti-trans healthcare legislation, it can be extremely difficult to find a knowledgeable, trans-affirming provider as well as access prescription medication. Many insurance plans do not cover HRT. For trans folks without insurance coverage, the ongoing out-of-pocket expense can be challenging.

What is the impact of this care on the recipient’s life?

Estogen+ introduces a wide range of feminizing physical, emotional, and psychological changes that align with their gender identity. This often leads to a more positive emotional well-being, increased confidence, increased safety when in public, and better opportunities at employment and more.